Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FCRH1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $16,584.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on November 6, 2025, is one of numerous orders placed with DMS Pharmaceutical Group under the agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The order carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. Performance is scheduled for completion by December 1, 2025, at the vendor's Park Ridge, Illinois location.
This delivery order operates under DMS Pharmaceutical Group's recently awarded single-award indefinite delivery contract (SPE2DR) under the PPV-G GEN V program, which carries a $499.999 billion ceiling and extends through December 31, 2036. The PPV-G GEN V represents a broader $30.3 billion Defense Logistics Agency acquisition strategy designed to establish multiple regional prime vendor contractors for pharmaceutical supply chain operations supporting Department of Defense military healthcare facilities globally. As a critical supplier within this federal pharmaceutical distribution network, DMS Pharmaceutical Group supplies a comprehensive portfolio of branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support recurring medical supply needs across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FCRH1?
SPE2DR26FCRH1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FCRH1 worth?
The government has obligated $16,584 on SPE2DR26FCRH1.
Is contract SPE2DR26FCRH1 an order under another contract?
Yes. SPE2DR26FCRH1 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRH1 competed?
The extent of competition for SPE2DR26FCRH1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award